Publications by authors named "Garry Fenton"

Claim this Profile
D
Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV.
Kenji Namoto, Finton Sirockin, Nils Ostermann, Francois Gessier, Stefanie Flohr, Garry Fenton

Bioorg Med Chem Lett· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.
Jon M Sutton, David E Clark, Stephen J Dunsdon, Garry Fenton, Amanda Fillmore

Bioorg Med Chem Lett· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of betaII tryptase.
Julian Levell, Peter Astles, Paul Eastwood, Jennifer Cairns, Olivier Houille, Garry Fenton

Bioorg Med Chem· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping the kinase domain of Janus Kinase 3.
Christopher Adams, David J Aldous, Shelley Amendola, Paul Bamborough, Colin Bright, Garry Fenton

Bioorg Med Chem Lett· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis